Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Moderna

U.S FDA Sets June Meeting For Moderna, Pfizer Small Children COVID-vaccines

The June 14 meeting will consider Moderna's emergency use authorization request for youth aged six to 17 years, the FDA said.White House COVID-19 response coordinator Dr. Ashish Jha said on Sunday he expects a U.S. Food and Drug Administration decision on authorizing Moderna's vaccine for children under age five within the next few weeks

Read More

COVID-19 Vaccine sales Push Moderna Q4 Profit To $12 Bn

Moderna's COVID-19 vaccine is the only product the drugmaker has on the market

Read More

Moderna COVID-19 Jabs Likely To Cause Heart Inflammation Than Pfizer's: Study

Earlier studies from Israel and the United States have indicated an increased risk of heart inflammation after inoculation with the mRNA-vaccines developed by Pfizer-BioNTech and Moderna.

Read More

Moderna Covid Vaccine Produces Lasting Immune Response, Study Finds

They found that the Moderna vaccine spurs an adaptive immune response to the SARS-CoV-2 spike protein nearly identical to the immune system's response to a natural infection.

Read More

Moderna, Japan Partner Recall 1.6 Million Doses

The companies on Aug. 26 announced suspension of 1.63 million doses produced at the line after reports of contamination.

Read More

Japan Suspends 1.63M Doses Of Moderna Over Contamination

The health ministry said contamination was reported from multiple vaccination sites. Some doses might have been administered, but no adverse health effects have been reported so far

Read More

No Sign Of Pfizer, Moderna Covid Vaccines In Breast Milk: Study

The researchers at University of California, San Francisco (USCF) in the US analysed the breast milk of seven women after they received the Pfizer and Moderna mRNA vaccines, and found no trace of the preventives.

Read More

India Offered 7.5 Mn Doses Of Moderna Vaccine; No Consensus On Indemnity Clause Yet: Sources

NITI Aayog member (Health) Dr V K Paul had recently said the government is working actively with Moderna to see how its vaccine can be imported and made available in the country.

Read More

Cases Of Lambda Covid-19 Variant Found In Canada

The Public Health Agency of Canada is monitoring Lambda to see how it spreads and how it responds to vaccines,

Read More

Pfizer, Moderna Vaccines Cut Covid-19 Risk By 91%: Study

The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.

Read More

Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU

The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.

Read More

Canada: Pfizer, Moderna Preferred 2nd Dose After AstraZeneca

On June 1, committee had said AstraZeneca recipients “could" get Pfizer or Moderna for their second shot if they wanted, but Thursday went further to say an mRNA vaccine was the ”preferred" choice.

Read More

VAV Lifesciences To Supply Key COVID Vaccine Ingredient To Pfizer, Moderna

The US firm will use the lipids made by VAV to produce gene-based lipid nanoparticles on behalf of the brand owners -- Pfizer-BioNTech and Moderna.

Read More

India Likely To Waive Customs Duty On COVID-19 Vaccine Imports

The government presently levies 10 per cent customs or import duty plus a 16.5 per cent I-GST and social welfare surcharge on vaccines coming from overseas

Read More

Pfizer Wants To Make Vaccine In India If Faster Clearance, Export Freedom Assured

The Serum Institute of India, the world's largest vaccine maker, is already bulk-manufacturing the Oxford University/AstraZeneca product and plans to start producing the Novavax Inc shot from next month.

Read More